Sponsor
Triangle Pharmaceuticals
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Triangle Pharmaceuticals appears in 11 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
11 shownA Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsNCT00006208 · lead sponsor · 2000-08-01
UNKNOWNA Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsNCT00002362 · lead sponsor · 1999-08-01
SUSPENDEDComparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug CombinationNCT00002416 · lead sponsor
COMPLETEDA Study of MKC-442 in HIV-Positive PatientsNCT00002413 · lead sponsor
COMPLETEDA Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-NaiveNCT00002215 · lead sponsor
COMPLETEDEmtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIVNCT00017992 · lead sponsor
UNKNOWNA Study of MKC-442 in Combination With Other Anti-HIV DrugsNCT00002412 · lead sponsor
COMPLETEDOnce Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAARTNCT00196612 · collaborator · 2001-04-01
COMPLETEDPilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected AdultsNCT00196599 · collaborator · 1999-02-01
COMPLETEDThe Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsNCT00002420 · collaborator
TERMINATEDThe Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsNCT00002418 · collaborator
TERMINATEDSponsor roles
lead sponsor7
collaborator4
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.